OLA1P3

Across TCGA pan-cancer cohorts, OLA1P3 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of OLA1P3’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where OLA1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OLA1P3 is over-expressed in tumor.

PRAD, KICH, and BRCA are the cancer types where OLA1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OLA1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.039	.003	2	view →
KICH	Male	IV	+0.036	.005	2	view →
BRCA	All	III,IV	+0.018	.010	2	view →
HNSC	Female	IV	+0.020	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

OLA1P3–PRAD

Open the PRAD breakdown →